跳至主要内容
临床试验/NL-OMON48295
NL-OMON48295招募中不适用

Identification of risk factors and biomarkers for liver diseases, hepatocellular carcinoma, cholangiocarcinoma and gallbladder carcinoma. The ESCALON stduy. - ESCALO

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 1,950 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
1,950

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • HPB related malignancies, • Age >= 18 years of age
  • Diagnosed with HCC, CCA or GBC
  • Written informed consent, HPB related diseases, • Age >= 18 years of age
  • Diagnosed with viral hepatitis, cirrhosis, PSC, NAFLD or gallstones
  • Written informed consent, Healthy controls, • Age >= 18 years of age
  • No signs of relevant disease
  • Written informed consent

排除标准

  • For all groups, • Females who are pregnant or breast-feeding.
  • History or other evidence of severe illness, other malignancy or any other
  • condition which would make the patient, in the opinion of the investigators,
  • unsuitable for the study.

研究者

相似试验